Diagnostic Performance of Nectin-4–targeted [68Ga]Ga-DOTA-N188 PET/CT versus [18F]-FDG PET/CT for Staging of Locally Advanced and Metastatic Urothelial Carcinoma: A Prospective, Single-center, Phase 2 Feasibility Trial

医学 放射科 尿路上皮癌 临床试验 梅德林 肿瘤科 临床研究阶段 相(物质) 转移 肿瘤分期 肾癌 内科学 外科 膀胱癌
作者
Ekaterina Laukhtina,Dina Muin,Clemens P. Spielvogel,Lukas Nics,Agata Suleja,Johanna Krauter,Eva Stöckel,Irene Hübner-Resch,Anka Mihajlovic,Stefan Schmitl,Elisabeth Kretschmer‐Chott,Bernhard Englinger,Sazan Rasul,Pascal Baltzer,Marcus Hacker,Shahrokh F. Shariat
出处
期刊:European Urology [Elsevier BV]
标识
DOI:10.1016/j.eururo.2026.10.018
摘要

Enfortumab vedotin (EV), an anti–nectin-4 antibody-drug conjugate, alone and with pembrolizumab (EV plus pembrolizumab [EV/P]), has transformed the treatment of locally advanced/metastatic urothelial carcinoma (la/mUC), yet remains biomarker agnostic. We prospectively evaluated [ 68 Ga]Ga-DOTA-N188 PET/CT ([ 68 Ga]-N188 PET/CT) as a whole-body alternative for nectin-4 imaging, with [ 18 F]-FDG PET/CT as an active comparator and conventional computed tomography as the reference standard for staging la/mUC in 25 patients planned for EV/P. [ 18 F]-FDG PET/CT showed a higher maximum standardized uptake value and tumor-to-background ratio than [ 68 Ga]-N188 PET/CT across most lesion types (primary tumor, visceral, and osseous), except for lymph nodes. The overall tracer correlation was weak (Spearman r = 0.196), strongest in lymph nodes ( r = 0.657), and absent in primary tumors and bone lesions. For primary tumor detection, [ 68 Ga]-N188 PET/CT had higher specificity (86% vs 57%) and positive predictive value (92% vs 83%) than FDG, which had higher sensitivity (88% vs 67%). Nodal staging performance was similar in the tracers. For distant metastases, both achieved 100% sensitivity and negative predictive value, with [ 68 Ga]-N188 PET/CT showing marginally higher specificity. [ 68 Ga]-N188 PET/CT is feasible for whole-body nectin-4 assessment in la/mUC and supports a distinct biodistribution from FDG, suggesting complementary rather than interchangeable roles. Further prospective evaluation with treatment-outcome correlation is warranted before its use as a biomarker to guide EV-based therapy selection.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Lllll完成签到,获得积分10
刚刚
常富育完成签到,获得积分10
刚刚
丘比特的应助被苗条梨愁采纳,获得10
刚刚
刚刚
酷波er的应助被Osborn采纳,获得10
刚刚
1秒前
万能图书馆的应助被ku采纳,获得10
1秒前
复杂代萱发布了新的文献求助10
1秒前
LIUCHEN发布了新的文献求助10
2秒前
123发布了新的文献求助10
2秒前
4秒前
黑米粥发布了新的文献求助200
4秒前
5秒前
5秒前
花未稀完成签到,获得积分10
5秒前
糖媛儿完成签到,获得积分20
6秒前
7秒前
lmn发布了新的文献求助10
7秒前
7秒前
大个的应助被丁真人采纳,获得10
8秒前
诸葛语琴完成签到,获得积分10
8秒前
8秒前
9秒前
janeli完成签到 ,获得积分10
9秒前
li发布了新的文献求助10
10秒前
10秒前
靳南希发布了新的文献求助30
11秒前
dolla发布了新的文献求助10
11秒前
CyberHamster完成签到,获得积分10
12秒前
12秒前
舒南晴发布了新的文献求助10
12秒前
林曦完成签到,获得积分10
12秒前
lzh发布了新的文献求助10
13秒前
13秒前
叽歪提发布了新的文献求助10
14秒前
14秒前
hu发布了新的文献求助10
15秒前
李时云完成签到,获得积分10
15秒前
刘一发布了新的文献求助10
15秒前
成熟稳重痴情完成签到,获得积分0
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183792
求助须知:如何正确求助?哪些是违规求助? 9573020
关于积分的说明 21828776
捐赠科研通 7780959
什么是DOI,文献DOI怎么找? 3434116
关于科研通互助平台的介绍 2558301
邀请新用户注册赠送积分活动 2480611